The University of Chicago Header Logo

Connection

Russell Szmulewitz to Heterocyclic Compounds, 1-Ring

Back to Details
This is a "connection" page, showing publications Russell Szmulewitz has written about Heterocyclic Compounds, 1-Ring.
Russell Szmulewitz
Connection Strength
0.246
Heterocyclic Compounds, 1-Ring
  1. [177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial. Lancet. 2026 Aug 29; 408(10557):793-807.
    View in: PubMed
    Score: 0.246
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.